TACROLIMUS AND METHOTREXATE WITH OR WITHOUT SIROLIMUS IN PREVENTING GRAFT-VERSUS-HOST DISEASE IN YOUNG PATIENTS UNDERGOING DONOR STEM CELL TRANSPLANT FOR ACUTE LYMPHOBLASTIC LEUKEMIA IN COMPLETE REMISSION: